Dennis L. Kasper MD
William Ellery Channing Professor of Medicine, Channing Laboratory
Join to View Full Profile
181 Longwood AveBoston, MA 02115
Phone+1 617-365-8110
Dr. Kasper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1973 - 1974
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1972 - 1973
NYU Grossman School of MedicineInternship, Internal Medicine, 1967 - 1968
University of Illinois College of MedicineClass of 1967
Certifications & Licensure
MA State Medical License 1973 - 2027
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2001
- Elected Member The American Society for Clinical Investigation, 1978
Publications & Presentations
PubMed
- 2 citationsThe gut microbiome and cancer response to immune checkpoint inhibitors.Francesca S Gazzaniga, Dennis L Kasper
The Journal of Clinical Investigation. 2025-02-03 - Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings.Maria Meira, Aurore Frey, Neila Chekkat, Magda Rybczynska, Zaki Sellam
Mabs. 2024-11-26 - The microbiome diversifies-acyl lipid pools - including short-chain fatty acid-derived compounds.Helena Mannochio-Russo, Vincent Charron-Lamoureux, Martijn van Faassen, Santosh Lamichhane, Wilhan D Gonçalves Nunes
Biorxiv. 2024-11-02
Press Mentions
Microbes in Your Gut May Be New Recruits in the Fight Against VirusesApril 13th, 2021- Gut Bacteria Trigger Immune Defense Mechanism to Protect Against Viral InfectionsNovember 19th, 2020
- How the Microbiome Rouses the Body’s Virus-Fighting PowersNovember 18th, 2020
- Join now to see all
Grant Support
- Gut complement system: Induction and protection against enteric infectionHARVARD MEDICAL SCHOOL2025–2029
- Tetraacylated lipid A enhancement of checkpoint blocking cancer immunotherapyHARVARD MEDICAL SCHOOL2023–2025
- Elucidating the Structural Requirements for Next-Gen Glycoconjugate VaccinesHARVARD MEDICAL SCHOOL2020–2024
- Knowledge-Based Vaccines Built On Paradigm Changes In Antigen PresentationNational Institute Of Allergy And Infectious Diseases2011–2012
- Commensal Bacteroides Signal Through Sphingolipid Rafts During Intestinal StressNational Institute Of Allergy And Infectious Diseases2011–2012
- New England Regional Center Of Excellence In Biodefense And Emerging Infectious DNational Institute Of Allergy And Infectious Diseases2009–2012
- Developmental ProjectsNational Institute Of Allergy And Infectious Diseases2009–2012
- Development Of A Conjugate Vaccine For The Prevention Of TularemiaNational Institute Of Allergy And Infectious Diseases2009–2012
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2012
- Infectious Disease And Basic Microbiological MechanismsNational Institute Of Allergy And Infectious Diseases1987–2011
- Development Of A Conjugate Vaccine For The Prevention Of TularemiaNational Institute Of Allergy And Infectious Diseases2008–2010
- New England Regional Center Of Excellence For Biodefens*National Institute Of Allergy And Infectious Diseases2004–2008
- Prevention Of Group B Streptococcal (GBS) DiseaseNational Institute Of Allergy And Infectious Diseases2007
- New England Regional Center Of Excellence For BiodefenseNational Institute Of Allergy And Infectious Diseases2003–2007
- Pathogenic Mechanisms Of Anaerobes In SepsisNational Institute Of Allergy And Infectious Diseases1997–2007
- Structure Of Bacterial Polysaccharides And The Degree Of IGG Switch AssociationNational Center For Research Resources2005
- Structure Of Bacterial PolysaccharidesNational Center For Research Resources2004
- Immunochemistry Of Group B Streptococcal PolysaccharidesNational Institute Of Allergy And Infectious Diseases1992–2001
- 9th International Congress On Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2000
- Cell Harvester &Multilabel CounterNational Center For Research Resources2000
- The Streptococcal InitiativeNational Institute Of Allergy And Infectious Diseases1997–2000
- 8th International Congress On Infectious DiseasesNational Institute Of Allergy And Infectious Diseases1998
- Group B Strep InitiativeNational Institute Of Allergy And Infectious Diseases1992–1997
- Pathogenic Mechanisms Of Anaerobes In SepsisNational Institute Of Allergy And Infectious Diseases1996
- Prevention Of Perinatal Group B Streptococcal InfectionsNational Institute Of Allergy And Infectious Diseases1991–1995
- Immunochemistry Of Group B Streptococcal PolysaccharidesNational Institute Of Allergy And Infectious Diseases1985–1991
- B. Fragilis--Pathogenic Mechanisms And ImmunityNational Institute Of Allergy And Infectious Diseases1986–1990
- B. Fragilis: Pathogenic Mechanisms And ImmunityNational Institute Of Allergy And Infectious Diseases1987–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
